543 related articles for article (PubMed ID: 17671191)
1. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
2. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
3. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
4. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.
Nishimura K; Ueda K; Sakakibara S; Ishikawa K; Chen J; Okuno T; Yamanishi K
J Hum Virol; 2001; 4(6):296-305. PubMed ID: 12082396
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.
Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC
Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794
[TBL] [Abstract][Full Text] [Related]
9. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.
Foreman KE; Friborg J; Kong WP; Woffendin C; Polverini PJ; Nickoloff BJ; Nabel GJ
N Engl J Med; 1997 Jan; 336(3):163-71. PubMed ID: 8988896
[TBL] [Abstract][Full Text] [Related]
10. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
11. Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
Brown HJ; McBride WH; Zack JA; Sun R
Antivir Ther; 2005; 10(6):745-51. PubMed ID: 16218174
[TBL] [Abstract][Full Text] [Related]
12. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation.
Arvanitakis L; Geras-Raaka E; Varma A; Gershengorn MC; Cesarman E
Nature; 1997 Jan; 385(6614):347-50. PubMed ID: 9002520
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.
Cerimele F; Curreli F; Ely S; Friedman-Kien AE; Cesarman E; Flore O
J Virol; 2001 Mar; 75(5):2435-43. PubMed ID: 11160746
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.
Harrison SM; Whitehouse A
FEBS Lett; 2008 Sep; 582(20):3080-4. PubMed ID: 18692049
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus in Kaposi's sarcoma occurring in immunosuppressed renal transplant recipients.
Kedda MA; Margolius L; Kew MC; Swanepoel C; Pearson D
Clin Transplant; 1996 Oct; 10(5):429-31. PubMed ID: 8930456
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
19. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
[TBL] [Abstract][Full Text] [Related]
20. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
Cho HJ; Yu F; Sun R; Lee D; Song MJ
Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
